You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STA-9090

Showing 1 - 25 of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Lung Cancer Trial in United States (Ganetespib (STA-9090) and crizotinib)

Completed
  • Advanced Lung Cancer
  • Ganetespib (STA-9090) and crizotinib
  • Basking Ridge, New Jersey
  • +4 more
Dec 28, 2020

Esophagogastric Cancer Trial in Boston (STA-9090)

Completed
  • Esophagogastric Cancer
  • STA-9090
  • Boston, Massachusetts
  • +2 more
Jul 31, 2020

Small Cell Lung Cancer Trial in Boston (STA-9090)

Completed
Has Results
  • Small Cell Lung Cancer
  • STA-9090
  • Boston, Massachusetts
  • +2 more
Apr 12, 2019

Gastroesophageal Junction Adenocarcinoma, Malignant Tumor of the Cervical Esophagus, Malignant Tumor of the Thoracic Esophagus

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 22, 2019

Ocular Melanoma Trial in Boston (STA-9090)

Completed
Has Results
  • Ocular Melanoma
  • STA-9090
  • Boston, Massachusetts
  • +2 more
Oct 16, 2018

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Hsp90 inhibitor STA-9090
  • +7 more
  • Baltimore, Maryland
  • +3 more
Aug 19, 2018

Malignant Peripheral Nerve Sheath Tumors (MPNST), Sarcoma Trial in United States (ganetespib, Sirolimus)

Completed
Has Results
  • Malignant Peripheral Nerve Sheath Tumors (MPNST)
  • Sarcoma
  • Santa Monica, California
  • +6 more
May 1, 2019

Breast Cancer Trial in Boston, Concord, Chapel Hill (Fulvestrant, Ganetespib)

Completed
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +4 more
Dec 10, 2018

Hepatocellular Carcinoma Trial in Boston (STA-9090)

Completed
  • Hepatocellular Carcinoma
  • STA-9090
  • Boston, Massachusetts
  • +2 more
Apr 23, 2018

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in New York (ganetespib, paclitaxel, trastuzumab)

Completed
  • HER2-positive Breast Cancer
  • +6 more
  • New York, New York
  • +1 more
Jun 13, 2018

Anesthesia, Local Trial in Alexandria (Inferior Alveolar Nerve Block administration with laser irradiation, Inferior Alveolar

Active, not recruiting
  • Anesthesia, Local
  • Inferior Alveolar Nerve Block administration with laser irradiation
  • Inferior Alveolar Nerve Block administration
  • Alexandria, Egypt
    Alexandria Faculty of Dentistry
Dec 11, 2022

Dehiscence, Alveolar Ridge Enlargement, Bone Loss, Alveolar Trial in Ferrara (Sub-Periosteal Peri-implant Augmented Layer

Recruiting
  • Dehiscence
  • +2 more
  • Sub-Periosteal Peri-implant Augmented Layer technique
  • Soft tissue augmentation
  • Ferrara, Italy
    Polo Odontoiatrico
Nov 9, 2022

Tumors Trial run by the NCI (Ziv-Aflibercept, Ganetespib)

Terminated
Has Results
  • Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2018

Healthy Volunteers Trial in Bron (fMRI)

Completed
  • Healthy Volunteers
  • fMRI
  • Bron, France
    Inserm U1208
Jan 11, 2022

Multiple Sclerosis Trial in La Laguna (Dry needling)

Completed
  • Multiple Sclerosis
  • Dry needling
  • La Laguna, Santa Cruz De Tenerife, Spain
    Hospital Universitario de Canarias
Apr 27, 2022

Prostate Cancer Trial in New York (68Ga-RM2 (RM2), PET/CT Scan)

Completed
Has Results
  • Prostate Cancer
  • 68Ga-RM2 (RM2)
  • PET/CT Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 27, 2021

Cephen Reagents in Context of Research Into Lupus Anticoagulants

Recruiting
  • Lupus Anticoagulant
    • Strasbourg, France
      Laboratoire d'Hématologie - Hôpitaux Universitaires de Strasbour
    Dec 10, 2021

    Melanoma Trial in Boston (STA-9090)

    Terminated
    Has Results
    • Melanoma
    • STA-9090
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 1, 2017

    Determination of Fibrin Activity in Plasma on STA-R® Prototype

    Completed
    • Blood Coagulation Disorders
    • +3 more
    • Routine hemostasis tests
    • +3 more
    • Clamart, France
      Hôpital d'Instruction des armées Percy - Laboratoire d'Hématolog
    Aug 10, 2020

    Surgery, E-learning Trial in Melle (Online course with proficiency test, Online course, Standard training group)

    Completed
    • Surgery
    • E-learning
    • Online course with proficiency test
    • +3 more
    • Melle, Oost-Vlaanderen, Belgium
      Orsi Academy
    Dec 18, 2020

    Stage I Hypopharyngeal Squamous Cell Carcinoma, Stage I Laryngeal Squamous Cell Carcinoma, Stage I Oral Cavity Squamous Cell

    Terminated
    • Stage I Hypopharyngeal Squamous Cell Carcinoma
    • +15 more
    • Atlanta, Georgia
    • +1 more
    Jul 22, 2016

    Gastrointestinal Stromal Tumor Trial in United States (Ganetespib)

    Completed
    Has Results
    • Gastrointestinal Stromal Tumor
    • Los Angeles, California
    • +3 more
    Feb 11, 2016

    Moyamoya Disease, Remote Ischemic Preconditioning Trial in Seongnam-si (RIPC with RIPostC)

    Completed
    • Moyamoya Disease
    • Remote Ischemic Preconditioning
    • RIPC with RIPostC
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      Seoul National Univ. Bundang Hospita
    Aug 21, 2018

    Colon Cancer, Rectal Cancer Trial in New York (STA-9090)

    Completed
    Has Results
    • Colon Cancer
    • Rectal Cancer
    • STA-9090
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 19, 2015